[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Eli Lilly's new study on LY4065967 shows promise, while the market also reacts to the potential risks of compounded GLP-1 alternatives.
A pharmaceutical company's stock ticker symbol.
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXX
1 Month: XXXXXX +297%
1-Year High: XXXXXX on 2025-07-17
1-Year Low: X on 2025-05-07
Social Network | X |
---|---|
Engagements | XXXXXX |
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +281%
1 Month: XXX +303%
1-Year High: XXX on 2025-07-17
1-Year Low: X on 2025-05-07
Social Network | X |
---|---|
Mentions | XXX |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $zldpf in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: X
1 Week: X -XX%
1 Month: X -XX%
1-Year High: X on 2025-05-01
1-Year Low: X on 2025-05-07
The most influential creators that mention $zldpf in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@AponiaAnalytics | X | XXXXX | XX | XXXXXX |
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% +18%
1-Year High: XXX% on 2025-06-13
1-Year Low: XX% on 2025-06-24
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXXX | XX% | XXXXX | XX% |
Total | XXXXX | XX% | XXXXXX | XX% | XXXXX | XX% |
Top assets mentioned In the posts about $zldpf in the last XX hours
Hims & Hers Health, Inc. (HIMS) Regeneron Pharmaceuticals Inc (REGN) Eli Lilly and Company (LLY)
Top topics mentioned In the posts about $zldpf in the last XX hours
manat, $vani, $hims, hims, $rhhby, $him, gibraltar pound, new era, pfe, $regn, eli, $lly
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🦉 With the study launched in late June early metabolic data could shape investor expectations. If absorption and excretion align the asset may gain strategic weight in Eli Lillys early pipeline. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 00:39:19 UTC 4960 followers, XXX engagements
"🦉 Eli Lilly is testing LY4065967 in a Phase X trial focused on how the drug behaves inside the bodyabsorption breakdown and elimination. It uses a radiolabeled version to track every move. Two dosing formats reveal how much actually gets used. $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 00:39:18 UTC 4960 followers, XXX engagements
"💼Eli Lillys New Study on LY4065967: Key Insights for Investors $LLY $NVO $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS"
@AponiaAnalytics on X 2025-07-18 00:39:18 UTC 4960 followers, XXX engagements
"🦉 Tirzepatide adds GIP receptor activation lowering IL-5 and IL-13 in asthma and cutting apnea events by over 25/hour in obesity-related sleep apnea. Effects appear partly independent of weight loss. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #respiratory #GLP1"
@AponiaAnalytics on X 2025-07-17 19:45:05 UTC 4960 followers, XXX engagements